Multicentre study to determine the cardiotoxicity of R-CHOP compared to R-COMP in patients with diffuse large B-cell lymphoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Doxorubicin; Doxorubicin liposomal; Prednisolone; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 30 Aug 2013 Biomarkers information updated
- 13 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology.
- 08 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.